Advances in Drug Treatments for Children and Adolescents with Autism and Other Pervasive Developmental Disorders

By Malone Richard P.   Gratz Silvia S.   Mary Anne Delaney   Hyman Susan B.  

CNS Drugs, Vol. 19, Iss. 11, 2005-01 ,pp. : 923-934

Adis International

Access to resources Recommend Favorite

Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs

By  

Current Neuropharmacology, Vol. 13, Iss. 2, 2015-03 ,pp. : 248-257

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of recent patent applications for the diagnosis and treatment of autism and pervasive developmental disorders

By Walker Michael A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 249-264

Informa Healthcare

Access to resources Recommend Favorite

Psychotropic drugs and the ECG: focus on the QTc interval

By Goodnick Paul J   Parra Francisco   Jerry Jason  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 479-498

Informa Healthcare

Access to resources Recommend Favorite

Potential for Early-Life Immune Insult Including Developmental Immunotoxicity in Autism and Autism Spectrum Disorders: Focus on Critical Windows of Immune Vulnerability

By Dietert Rodney  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 11, Iss. 8, 2008-10 ,pp. : 660-680

Taylor & Francis Ltd

Access to resources Recommend Favorite